Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Willson

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|March 26, 1983
New doppler technique for assessing uteroplacental blood flowS Campbell, J Diaz-Recasens, D R Griffin, et al.
The Journal of Cell Biology|January 1, 1992
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vectorS P Wu, D Theodorescu, R S Kerbel, et al.
Cancer Treatment Reports|October 1, 1986
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group StudyJ K Willson, M W Knuiman, R T Skeel, et al.
Cancer Research|December 1, 1990
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesisS J Baker, A C Preisinger, J M Jessup, et al.
Journal of Interferon Research|April 1, 1988
Lack of interferon production by dipyridamoleK A Havlin, A D Inglot, J K Willson, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 28, 1998
Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatographyT L Stefan, S T Ingalls, P E Minkler, et al.
In Vitro Cellular & Developmental Biology. Animal|July 1, 1993
A better defined medium for human prostate cancer cellsT G Pretlow, G S Ogrinc, S B Amini, et al.
Cancer Research|June 15, 1989
Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell linesN W Toribara, T L Sack, J R Gum, et al.
International Journal of Oncology|February 10, 1998
A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cellsY Ko, K M Koli, S S Banerji, et al.
Nature|April 1, 1998
Mutations of mitotic checkpoint genes in human cancersD P Cahill, C Lengauer, J Yu, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|March 26, 1983
New doppler technique for assessing uteroplacental blood flowS Campbell, J Diaz-Recasens, D R Griffin, et al.
The Journal of Cell Biology|January 1, 1992
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vectorS P Wu, D Theodorescu, R S Kerbel, et al.
Cancer Treatment Reports|October 1, 1986
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group StudyJ K Willson, M W Knuiman, R T Skeel, et al.
Cancer Research|December 1, 1990
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesisS J Baker, A C Preisinger, J M Jessup, et al.
Journal of Interferon Research|April 1, 1988
Lack of interferon production by dipyridamoleK A Havlin, A D Inglot, J K Willson, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 28, 1998
Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatographyT L Stefan, S T Ingalls, P E Minkler, et al.
In Vitro Cellular & Developmental Biology. Animal|July 1, 1993
A better defined medium for human prostate cancer cellsT G Pretlow, G S Ogrinc, S B Amini, et al.
Cancer Research|June 15, 1989
Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell linesN W Toribara, T L Sack, J R Gum, et al.
International Journal of Oncology|February 10, 1998
A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cellsY Ko, K M Koli, S S Banerji, et al.
Nature|April 1, 1998
Mutations of mitotic checkpoint genes in human cancersD P Cahill, C Lengauer, J Yu, et al.
Pageof 17